Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 1281 - 1300 of 45480
HSR Informal Interpretations

2303003 Informal Interpretation

… 2303003 Informal Interpretation 2303003 Informal Interpretation From: Whitehead, Nora <nwhitehead@ftc.gov&gt; Sent: Monday, March 27, 2023 2:16:42 PM (UTC-05:00) … Time (US & Canada) To: [Redacted] Cc: HSRHelp <HSRHelp@ftc.gov&gt; Subject: RE: Question concerning Item 6(a) Report all …
Date
Rule
Item 6(a)
Report all controlled US entities, regardless of whether they have sales in or into the US (subject to the $10MM threshold you reference below). For more guidance, see https://www.ftc.gov/enforcement...
Cases and Proceedings
Commissioner Statements

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule

… Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the Notice of …
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
P064202
Amicus Briefs

Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al.

… Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al. Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. …
Date
Federal Court
District of Delaware
The Federal Trade Commission filed an amicus brief with the U.S. District Court for the District of Delaware in the case of Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al. The...
Cases and Proceedings

Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v.

… U.S. v. Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v. In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act , suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed …

In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act, suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed Health & Wellness Resource Center, a medical clinic, for making a wide range of false or unsupported claims for addiction treatment services, cancer treatment services, and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. Akoury and her AWAREmed clinic from making such unsupported claims and requires her to pay a $100,000 civil penalty.

 

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123039
Docket Number
2:23-CV-00026
Case Status
Pending
Displaying 1281 - 1300 of 45480
Return to top